-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE
Blog
Steps Healthcare Organizations Can Take to Prepare for Cures Act Interoperability Standards
Approaches to ease into the 21st Century Cures Act regulatory requirements
Aug 27, 2020
Since the final 21st Century Cures Act (Cures Act) rules were released in March 2020, the nation has been facing a global pandemic, which coincidentally underscores the need for greater healthcare data interoperability.
Now is the time when healthcare organizations must begin preparing to comply with the Cures Act. They should begin assessing their health information exchange capabilities, and the changes or additions that are needed to comply with the Trusted Exchange Framework and Common Agreement (TEFCA).
While healthcare technology vendors are designing changes to capture the additional data elements that will be required under the Cures Act, others are developing new applications to facilitate the use and management of health data by patients.
Data identification
A first step toward compliance with the Cures Act requirements is identifying tools, systems and applications that hold data elements needed to support interoperability. Once you have identified the data source, gaps in data collection can then documented and remediated. This is a good time to start, or in some instances, accelerate the principles of data management.
Understanding the qualified data is essential when preparing for interoperability, because every business process captures and maintains data differently. Some leverage structured data elements in an exact model, while others maintain data in unstructured, free form fields. Within a healthcare organization, multiple systems are often encountered with the only consistency being the inconsistencies in identifying, capturing, and storing data.
In addition, data quality is critical to producing easily integrated data. Healthcare organizations should start a baseline for their data quality metrics to help focus efforts on those areas that will need improvement to support data collection and transmission.
Data mapping
After identifying all relevant data sources, the process of mapping data fields to the Health Level 7 (HL7) transaction sets, and the U.S. Core Data for Interoperability (USCDI) standards, can begin.
Since designating HL7 FHIR (Release 4) as the standard for Healthcare Information Exchange, mapping your data sources, formats, and fields to the standard formats is necessary for exchanging data. This also necessitates discussion about how your organization will accept external data and incorporate the health data into the patients’ record without adding complexity or clutter to the record set.
Compliance strategy and implementation plan
Once you have assessed your healthcare organization’s existing processes and systems, a strategy and implementation plan are documented. A compliance strategy needs to account for the outcomes from all assessments and outline the steps, technologies, skills/people, and funding required to adhere to the new information exchange standards.
Healthcare organizations must prepare by assessing the efforts needed to update their technology systems, defining a path forward and getting certified to exchange healthcare information.
IQVIA can help your healthcare organization in addressing the challenges of assessing, defining and implementing the technology needed to support interoperability. Together, we can embrace the vision of the 21st Century Cures Act and improve the care and quality all members and patients deserve.
Cures Act: Getting Ready for the Implementation of TEFCA and Healthcare Interoperability Standards
In this white paper, IQVIA experts walk through the 21st Century Cures Act and the set of final rules mandating regulatory compliance for healthcare information exchange.